Showing results (261-270 of 369) with videos related to
Sort By:
Pageof 37
Blood|January 1, 1988
Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adultsD Hoelzer, E Thiel, H Löffler, et al.Blood|June 15, 1992
In vitro culture of common acute lymphoblastic leukemia blasts: effects of interleukin-3, interleukin-7, and accessory cellsM Eder, O G Ottmann, T E Hansen-Hagge, et al.Deutsche Medizinische Wochenschrift (1946)|December 4, 2004
[The competence network "acute and chronic leukemias"]R Hehlmann, U Berger, C Aul, et al.Der Internist|March 9, 2004
[Clinical research in the "acute and chronic leukemias"competence network ]R Hehlmann, U Berger, C Aul, et al.Onkologie|February 1, 1988
[Intensive combined therapy for high-risk ALL patients]D Hoelzer, E Thiel, H Löffler, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 1999
Autoimmunity resulting from cytokine treatment predicts long-term survival in patients with metastatic renal cell cancerA Franzke, D Peest, M Probst-Kepper, et al.The Journal of Experimental Medicine|July 21, 1997
The human C3a receptor is expressed on neutrophils and monocytes, but not on B or T lymphocytesU Martin, D Bock, L Arseniev, et al.Cancer|February 1, 1992
Treatment of relapsed or refractory adult acute lymphocytic leukemiaM Freund, H Diedrich, A Ganser, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1995
Bcl-xL rescues WEHI 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuliW Fang, J J Rivard, J A Ganser, et al.American Journal of Clinical Oncology|January 1, 1991
Clinical effects of recombinant human interleukin-3A Ganser, A Lindemann, G Seipelt, et al.Pageof 37